Modulation of intrathecal morphine-induced immunosuppression by microinjection of naloxone into periaqueductal gray

Zhongguo Yao Li Xue Bao. 1998 Nov;19(6):519-22.

Abstract

Aim: To study the involvement of opioid receptor of periaqueductal gray (PAG) and hypothalamic-pituitary-adrenal (HPA) axis in the effect of intrathecal morphine on immune function.

Methods: Rat splenic natural killer (NK) cell activity was determined by a europium release assay; the concanavalin A-induced splenic IL-2 production, TNF-beta activity, and serum TNF-alpha level were determined by colorimetric thiazolyl blue tetrazolium bromide (MTT) and gentian violet assay, and serum corticotrophin (ACTH) level by radio-immunological method after intrathecal injection of morphine and PAG microinjection of naloxone.

Results: Intrathecal morphine inhibited splenic NK cell activity, IL-2 production, TNF-beta activity, and increased in serum ACTH level. Microinjection of naloxone 1 microgram into PAG partially antagonized the inhibition of NK cell activity and the elevation of serum ACTH level by morphine.

Conclusion: The opioid receptor of PAG involved in the suppression of NK cell activity by intrathecal morphine, which was accompanied by an activation of HPA axis.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adrenocorticotropic Hormone / blood
  • Animals
  • Injections, Spinal
  • Interleukin-2 / biosynthesis
  • Killer Cells, Natural / immunology*
  • Lymphotoxin-alpha / metabolism
  • Male
  • Microinjections
  • Morphine / antagonists & inhibitors*
  • Naloxone / pharmacology*
  • Narcotic Antagonists / pharmacology
  • Periaqueductal Gray / physiology*
  • Rats
  • Rats, Wistar
  • Receptors, Opioid / physiology
  • Tumor Necrosis Factor-alpha / metabolism

Substances

  • Interleukin-2
  • Lymphotoxin-alpha
  • Narcotic Antagonists
  • Receptors, Opioid
  • Tumor Necrosis Factor-alpha
  • Naloxone
  • Morphine
  • Adrenocorticotropic Hormone